Oppenheimer gives an Outperform recommendation for Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc’s filing revealed that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.1 million. Then, Ege David S. […]

Recent Insider Activity Could Benefit Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc’s recently made public that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.11 million. Then, Ege David […]

Analyzing Seres Therapeutics Inc (MCRB) After Recent Trading Activity

CHWY Stock

Seres Therapeutics Inc’s filing revealed that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.1 million. Then, Ege David S. […]

Seres Therapeutics Inc [MCRB] Insider Activity: An Update for Investors

In a filing, Seres Therapeutics Inc revealed its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.14 million. Then, Ege David S. […]

Seres Therapeutics Inc [NASDAQ: MCRB] Sees Increase in Stock Value

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Seres Therapeutics Inc shares valued at $12,473 were sold by Shaff Eric D. on Feb 16. At $1.08 per share, Shaff Eric D. sold 11,549 shares. The insider’s holdings dropped to […]

Seres Therapeutics Inc (MCRB) Becoming More Attractive for Investors

Seres Therapeutics Inc’s recent filing unveils that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.14 million. Then, Ege David S. […]

Analyzing Seres Therapeutics Inc (MCRB) After Recent Trading Activity

In a filing, Seres Therapeutics Inc revealed its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $0.14 million. Then, Ege David S. […]

Seres Therapeutics Inc [MCRB] Stock sold by Insider Shaff Eric D. for $11545.0

Seres Therapeutics Inc’s filing revealed that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $11545.0 on Oct 30. In the deal valued at $1.35 per share,8,552 shares were sold. As a result of this transaction, Shaff Eric D. now holds 115,620 shares worth roughly $0.12 million. Then, von Moltke Lisa sold […]